- Home
- RWT vs SGP Comparison
RWT vs SGP Comparison
Compare RWT & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RWT | SGP |
|---|---|---|
| Founded | 1994 | 2019 |
| Country | United States | United States |
| Employees | 351 | 65 |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 648.6M | 650.9M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | RWT | SGP |
|---|---|---|
| Price | $4.72 | $18.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $6.82 | ★ $45.00 |
| AVG Volume (30 Days) | ★ 1.4M | 67.3K |
| Earning Date | 04-29-2026 | 05-15-2026 |
| Dividend Yield | ★ 12.83% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $26.59 | N/A |
| Revenue Next Year | $22.21 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.71 | $17.06 |
| 52 Week High | $6.97 | $30.56 |
Technical Indicators
Market Signals| Indicator | RWT | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 27.66 | 44.16 |
| Support Level | N/A | $17.33 |
| Resistance Level | $5.40 | $20.25 |
| Average True Range (ATR) | 0.15 | 1.14 |
| MACD | -0.04 | 0.29 |
| Stochastic Oscillator | 0.76 | 57.88 |
Price Performance
Historical ComparisonAbout RWT Redwood Trust Inc.
Redwood Trust Inc is a specialty finance company focused on several distinct areas of housing credit. The company delivers customized housing credit investments to a diverse mix of investors through securitization platforms, whole-loan distribution activities, and its publicly traded securities. The company has four reportable segments: Sequoia Mortgage Banking, CoreVest Mortgage Banking, Redwood Investments, and Legacy Investments. Maximum revenue is generated from the Sequoia Mortgage Banking segment, comprising a mortgage loan conduit that acquires residential consumer loans from third-party originators for subsequent sale to whole loan buyers, securitization through its SEMT private-label securitization program, or transfer into its Redwood Investments portfolio.
About SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.